Search Results

There are 10710 results for: content related to: Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions

  1. Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab

    Clinical & Experimental Allergy

    Volume 43, Issue 6, June 2013, Pages: 659–664, A. Matucci, S. Pratesi, G. Petroni, F. Nencini, G. Virgili, M. Milla, E. Maggi and A. Vultaggio

    Article first published online : 28 MAY 2013, DOI: 10.1111/cea.12098

  2. Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre

    British Journal of Dermatology

    Volume 167, Issue 2, August 2012, Pages: 411–416, J.S. Wee, G. Petrof, K. Jackson, J.N.W.N. Barker and C.H. Smith

    Article first published online : 11 JUN 2012, DOI: 10.1111/j.1365-2133.2012.10931.x

  3. Infliximab for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Barbara BTB Blumenauer, Maria Judd, George A Wells, Amanda Burls, Ann Cranney, Marc C Hochberg, Peter Tugwell and Maria Angeles Lopez-Olivo

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD003785

  4. Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2

    Journal of Medical Virology

    Volume 85, Issue 4, April 2013, Pages: 716–722, Manola Comar, Serena Delbue, Loredana Lepore, Stefano Martelossi, Oriano Radillo, Luca Ronfani, Pierlanfranco D'Agaro and Pasquale Ferrante

    Article first published online : 30 JAN 2013, DOI: 10.1002/jmv.23525

  5. You have free access to this content
    Arthritis & Rheumatism, 2001 Annual Scientific Meeting Abstracts, November 10–15, 2001, San Francisco, CA

    Arthritis & Rheumatism

    Volume 44, Issue S9, September 2001, Pages: 53–165,

    Article first published online : 22 FEB 2002, DOI: 10.1002/1529-0131(200109)44:9+<::AID-ART425>3.0.CO;2-A

  6. Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 118–128, David Ternant, Emilie Ducourau, Aleth Perdriger, Anca Corondan, Benoît Le Goff, Valérie Devauchelle-Pensec, Elisabeth Solau-Gervais, Hervé Watier, Philippe Goupille, Gilles Paintaud and Denis Mulleman

    Article first published online : 20 JUN 2014, DOI: 10.1111/bcp.12313

  7. You have free access to this content
    Costs of care for Crohn’s disease following the introduction of infliximab: a single-centre UK experience

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 11-12, December 2010, Pages: 1357–1363, M. B. Sprakes, A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett and P. J. Hamlin

    Article first published online : 6 OCT 2010, DOI: 10.1111/j.1365-2036.2010.04482.x

  8. You have free access to this content
    Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 6, November 2004, Pages: 801–810, Mihaela Ringheanu, Fredric Daum, James Markowitz, Jeremiah Levine, Seymour Katz, Xingyu Lin and Jack Silver

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200411000-00015

  9. You have free access to this content
    Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

    British Journal of Clinical Pharmacology

    Volume 73, Issue 1, January 2012, Pages: 55–65, David Ternant, Denis Mulleman, Francine Lauféron, Céline Vignault, Emilie Ducourau, Daniel Wendling, Philippe Goupille and Gilles Paintaud

    Article first published online : 8 DEC 2011, DOI: 10.1111/j.1365-2125.2011.04050.x

  10. Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

    The Journal of Clinical Pharmacology

    Volume 48, Issue 6, June 2008, Pages: 681–695, Zhenhua Xu, Kathleen Seitz, Adedigbo Fasanmade, Joyce Ford, Paul Williamson, Weichun Xu, Hugh M. Davis and Honghui Zhou

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008316886

  11. You have free access to this content
    Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1199–1206, Benjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, Marine Desroches, Gauthier Louis, Chiara De Cassan, Clotilde Baudry, Jean-Marc Gornet, Pierre Desreumaux, Dominique Emilie, Jean-Frédéric Colombel and Matthieu Allez

    Article first published online : 29 AUG 2011, DOI: 10.1002/ibd.21839

  12. You have free access to this content
    Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Nilesh Chande, David J Tsoulis and John K MacDonald

    Published Online : 30 APR 2013, DOI: 10.1002/14651858.CD000545.pub4

  13. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Article first published online : 17 JUN 2011, DOI: 10.1002/pds.2132

  14. Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases

    Drug Development Research

    Volume 75, Issue 3, May 2014, Pages: 115–161, Frank R. Brennan, Annick Cauvin, Jay Tibbitts and Alison Wolfreys

    Article first published online : 29 APR 2014, DOI: 10.1002/ddr.21173

  15. You have free access to this content
    Tumor Necrosis Factor Alpha Inhibitors as Immunomodulatory Antirejection Agents after Intestinal Transplantation

    American Journal of Transplantation

    Volume 11, Issue 5, May 2011, Pages: 1041–1050, U. A. Gerlach, M. Koch, H.-P. Müller, W. Veltzke-Schlieker, P. Neuhaus and A. Pascher

    Article first published online : 26 APR 2011, DOI: 10.1111/j.1600-6143.2011.03497.x

  16. INFECTION-RELATED RHEUMATIC DISEASES

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A80–A83,

    Article first published online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_14.x

  17. You have free access to this content
    The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 46, Issue 6, June 2002, Pages: 1451–1459, E. William St.Clair, Carrie L. Wagner, Adedigbo A. Fasanmade, Benjamin Wang, Thomas Schaible, Arthur Kavanaugh and Edward C. Keystone

    Article first published online : 6 JUN 2002, DOI: 10.1002/art.10302

  18. CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Page: A39,

    Article first published online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_6.x

  19. RHEUMATOID ARTHRITIS – CLINICAL ASPECTS

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A167–A188,

    Article first published online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_23.x

  20. EPIDEMIOLOGY OF RHEUMATIC DISEASES

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A54–A66,

    Article first published online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_10.x